# SNF Holdings, LLC dba Vios Compounding – FDA Inspection, Mar 2, 2023

Source: https://www.keypedia.com/records/fda_inspections/snf-holdings-llc-dba-vios-compounding/92606db8-5e70-475b-bdac-31f544b3034f
Source feed: FDA_Inspections

> FDA inspection 1201524 of SNF Holdings, LLC dba Vios Compounding, March 02, 2023. Classification: Voluntary Action Indicated (VAI). 5 citations. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201524
- Company Name: SNF Holdings, LLC dba Vios Compounding
- Inspection Date: 2023-03-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5
- Enforcement Type: STATE_REFERRAL_LETTER

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/alan-m-barker/cf7b4907-0505-418e-860c-815acd534afe)
- [FDA Associated Person](https://www.keypedia.com/people/jacob-g-lutz/ca2710c6-064f-4728-9129-aad73e74f12d)
- [Issuing Officer](https://www.keypedia.com/people/wenning-chan/973bf578-405d-46cf-b09e-254d6db07c08)

Company: https://www.keypedia.com/companies/snf-holdings-llc-dba-vios-compounding/24756366-4a12-4ec7-9d0c-3fa72b984f81

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
